TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2015-08-0716:49 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001387131-15-002352 |
| 2015-08-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-15-002323 |
| 2015-07-1516:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-15-253673 |
| 2015-06-2308:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-001982 |
| 2015-06-1517:07 ET | 8-K | 5.07 Shareholder vote results | 0001387131-15-001944 |
| 2015-06-0907:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-001914 |
| 2015-05-0717:00 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001387131-15-001534 |
| 2015-05-0516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-15-001467 |
| 2015-04-3020:20 ET | DEF 14A | Proxy statementPeriod 2015-06-11 | 0001193125-15-157717 |
| 2015-03-3116:34 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001387131-15-001139 |
| 2015-03-1808:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-000921 |
| 2015-03-1216:36 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001387131-15-000875 |
| 2015-03-1016:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-15-000813 |
| 2015-02-1717:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001387131-15-000590 |
| 2015-01-1216:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-000068 |
| 2014-11-1808:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-14-003839 |
| 2014-11-0717:04 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001387131-14-003647 |
| 2014-11-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-14-003626 |
| 2014-08-0716:44 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001387131-14-002744 |
| 2014-08-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-14-002712 |
| 2014-08-0416:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-14-293543 |
| 2014-07-3016:48 ET | 8-K | 8.01 Other events | 0001193125-14-287056 |
| 2014-06-1116:45 ET | 8-K | 5.07 Shareholder vote results | 0001387131-14-002185 |
| 2014-05-0708:52 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001387131-14-001673 |
| 2014-05-0607:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-14-001658 |
| 2014-05-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-14-001651 |
| 2014-04-1717:02 ET | DEF 14A | Proxy statementPeriod 2014-06-05 | 0001193125-14-147850 |
| 2014-04-0816:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-14-001325 |
| 2014-03-2815:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-14-121163 |
| 2014-03-2116:46 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-14-110466 |
| 2014-03-0517:10 ET | 10-K | Annual reportPeriod 2013-12-31 | 0001387131-14-000771 |
| 2014-03-0416:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-14-000739 |
| 2014-03-0316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-14-000717 |
| 2013-12-1808:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-13-004709 |
| 2013-11-2716:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-13-004524 |
| 2013-11-2716:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-13-004522 |
| 2013-11-0617:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-13-004117 |
| 2013-11-0507:11 ET | 10-Q | Quarterly reportPeriod 2013-09-30 | 0001387131-13-004064 |
| 2013-11-0417:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-13-004055 |
| 2013-10-0817:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-13-003747 |
| 2013-09-2517:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-13-378619 |
| 2013-09-2509:30 ET | 8-K | 8.01 Other events | 0001193125-13-377277 |
| 2013-09-2417:02 ET | 8-K | 8.01 Other events | 0001193125-13-376468 |
| 2013-08-2817:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-13-003202 |
| 2013-08-2216:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001387131-13-003145 |
| 2013-08-0706:07 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001387131-13-002760 |
| 2013-08-0608:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-13-002719 |
| 2013-07-1206:06 ET | DEF 14A | Proxy statementPeriod 2013-08-22 | 0001193125-13-288738 |
| 2013-06-1408:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-13-002200 |
| 2013-06-0417:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-13-002092 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.